CrowdStrike Holdings Valuation
Is CRWD * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CRWD * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CRWD * (MX$5122.46) is trading above our estimate of fair value (MX$5075.85)
Significantly Below Fair Value: CRWD * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CRWD *?
Other financial metrics that can be useful for relative valuation.
| What is CRWD *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$73.55b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 23.2x |
| Enterprise Value/EBITDA | 669.1x |
| PEG Ratio | 23.8x |
Price to Sales Ratio vs Peers
How does CRWD *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 10.1x | ||
PANW Palo Alto Networks | 12.6x | 13.0% | US$94.0b |
FTNT Fortinet | 9.3x | 11.9% | US$49.0b |
VMW VMware | 4.5x | 7.6% | US$61.5b |
ZS Zscaler | 14.2x | 19.3% | US$26.5b |
CRWD * CrowdStrike Holdings | 24.1x | 19.0% | Mex$73.5b |
Price-To-Sales vs Peers: CRWD * is expensive based on its Price-To-Sales Ratio (24.1x) compared to the peer average (12x).
Price to Earnings Ratio vs Industry
How does CRWD *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: CRWD * is expensive based on its Price-To-Sales Ratio (24.1x) compared to the Global Software industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is CRWD *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 24.1x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CRWD *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$5,122.46 | Mex$6,648.39 +29.8% | 12.1% | Mex$9,190.80 | Mex$3,341.03 | n/a | 49 |
| Apr ’25 | Mex$5,320.00 | Mex$6,513.06 +22.4% | 12.5% | Mex$9,010.87 | Mex$3,275.62 | n/a | 47 |
| Mar ’25 | Mex$5,370.00 | Mex$5,482.94 +2.1% | 18.0% | Mex$9,190.04 | Mex$3,340.75 | n/a | 45 |
| Feb ’25 | Mex$5,115.00 | Mex$5,079.06 -0.7% | 18.3% | Mex$9,292.70 | Mex$3,011.52 | n/a | 47 |
| Jan ’25 | Mex$4,336.00 | Mex$4,254.47 -1.9% | 13.4% | Mex$5,581.06 | Mex$2,959.65 | n/a | 46 |
| Dec ’24 | Mex$4,051.44 | Mex$3,978.93 -1.8% | 9.7% | Mex$4,691.99 | Mex$3,029.88 | n/a | 46 |
| Nov ’24 | Mex$3,174.00 | Mex$3,566.34 +12.4% | 9.9% | Mex$4,542.10 | Mex$2,779.77 | n/a | 45 |
| Oct ’24 | Mex$2,940.00 | Mex$3,428.37 +16.6% | 9.9% | Mex$4,420.88 | Mex$2,705.58 | n/a | 46 |
| Sep ’24 | Mex$2,766.00 | Mex$3,142.74 +13.6% | 10.9% | Mex$4,262.83 | Mex$2,557.70 | n/a | 45 |
| Aug ’24 | Mex$2,804.00 | Mex$2,968.13 +5.9% | 11.8% | Mex$3,934.93 | Mex$2,143.28 | n/a | 46 |
| Jul ’24 | Mex$2,465.00 | Mex$3,017.09 +22.4% | 11.8% | Mex$4,012.98 | Mex$2,185.79 | n/a | 47 |
| Jun ’24 | Mex$2,765.00 | Mex$3,029.16 +9.6% | 11.5% | Mex$4,125.05 | Mex$2,246.84 | n/a | 44 |
| May ’24 | Mex$2,165.00 | Mex$2,997.83 +38.5% | 13.1% | Mex$4,213.22 | Mex$2,241.08 | n/a | 43 |
| Apr ’24 | Mex$2,465.00 | Mex$3,157.39 +28.1% | 13.4% | Mex$4,451.09 | Mex$2,367.60 | Mex$5,320.00 | 43 |
| Mar ’24 | Mex$2,175.00 | Mex$2,917.72 +34.1% | 17.7% | Mex$4,300.12 | Mex$2,012.82 | Mex$5,370.00 | 42 |
| Feb ’24 | Mex$2,056.49 | Mex$2,988.23 +45.3% | 17.7% | Mex$4,375.94 | Mex$2,048.31 | Mex$5,115.00 | 42 |
| Jan ’24 | Mex$1,937.00 | Mex$3,504.53 +80.9% | 23.9% | Mex$7,561.02 | Mex$2,356.68 | Mex$4,336.00 | 38 |
| Dec ’23 | Mex$2,340.00 | Mex$3,480.54 +48.7% | 23.2% | Mex$7,374.94 | Mex$2,298.68 | Mex$4,051.44 | 37 |
| Nov ’23 | Mex$3,247.00 | Mex$4,771.56 +47.0% | 13.0% | Mex$7,710.13 | Mex$3,865.08 | Mex$3,174.00 | 37 |
| Oct ’23 | Mex$3,430.00 | Mex$4,791.07 +39.7% | 13.6% | Mex$7,753.32 | Mex$3,886.73 | Mex$2,940.00 | 34 |
| Sep ’23 | Mex$3,435.00 | Mex$4,831.86 +40.7% | 14.0% | Mex$7,771.61 | Mex$3,794.97 | Mex$2,766.00 | 30 |
| Aug ’23 | Mex$3,725.00 | Mex$4,777.71 +28.3% | 15.2% | Mex$7,909.21 | Mex$3,862.16 | Mex$2,804.00 | 30 |
| Jul ’23 | Mex$3,606.00 | Mex$4,739.66 +31.4% | 15.5% | Mex$7,832.71 | Mex$3,824.80 | Mex$2,465.00 | 31 |
| Jun ’23 | Mex$3,220.00 | Mex$4,747.86 +47.4% | 13.8% | Mex$6,002.89 | Mex$3,562.37 | Mex$2,765.00 | 30 |
| May ’23 | Mex$4,165.61 | Mex$5,510.06 +32.3% | 9.9% | Mex$6,885.88 | Mex$4,293.55 | Mex$2,165.00 | 30 |
| Apr ’23 | Mex$4,546.50 | Mex$5,398.29 +18.7% | 12.3% | Mex$6,971.09 | Mex$4,018.63 | Mex$2,465.00 | 31 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.